Leading the Way in Life Science Technologies

GEN Exclusives

More »

August 1, Vol. 34, No. 14

  • Columns

    • FDA Gets Social with Biopharmas
    • Alex Philippidis
    • Despite all the hype about its transforming business relationships, half of the top 50 pharmaceutical companies make no use of social media, according to an IMS report released in January The report showed only one pharma using social media effectively—Johnson ... more »
    • Enzymatics Enriches NGS with AMP
    • Gail Dutton
    • In transforming itself from a reagents supplier to a next-generation sequencing (NGS) applications company, Enzymatics is advancing the genomics industry While Enzymatics continues to support and expand its fast-growing core business—reagents and kits for original equipment manufacturers—it is also taking ... more »
    • Embracing the Innovation Imperative
    • Over the next 5–10 years, biotechnology will face unique challenges related to innovation, regulation, and economics The industry will attempt to overcome these challenges by developing novel drug classes and continuously improving manufacturing operations The threat from Asian manufacturers, ... more »